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The publisher regrets that there was an error in Figure 3E at the time the article was published. This has now been corrected






Neutrophils at day 0 [× 109/l]The publisher would like to apologise for any inconvenience caused.DOI of original article: https://doi.org/10.1016/j.esmoop.2020.100005
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